Cardiac Drug Therapy

Dr. M. Gabriel Khan is a cardiologist at the Ottawa Hospital and an Associate Profes­sor of Medicine, at the University of Ottawa. Dr. Khan graduated MB, BCh, with First-Class Honours at The Queen’s University of Belfast. He obtained , by thesis, the Degree  of  Doctor of Medicine  with  Honours ( QUB). He is the author of Encyclopedia of Heart Diseases, Academic Press/ Elsevier, 2006; Encyclopedia of Heart Diseases,  2nd ed., Springer Science+Business Media,  2011; Rapid ECG Interpretation, 3rd ed.,  Humana Press/Springer Science+Business Media, 2008;  On Call Cardiology, 3rd  ed., Elsevier, 2006; Heart Disease Diagnosis and Therapy, 2nd ed., Humana Press, 2006; Cardiac and Pulmonary Management (1993); Medical Diagnosis and Therapy (1994); Heart Attacks, Hypertension and Heart Drugs (1986); and Heart Trouble Encyclopedia (1996).

Beta-Blockers: The Cornerstone of Cardiac Drug Therapy.- Beta-Blocker Controversies.- Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.- ACE Inhibitor Controversies.- Calcium Antagonists (Calcium Channel Blockers).- Calcium Antagonist Controversies.- Diuretics.- Hypertension.- Hypertension Controversies.- Angina.- Acute Myocardial Infarction.- Heart Failure.- Heart Failure Controversies.- Management of Cardiac Arrhythmias.- Cardiac Arrest.- Management of Infective Endocarditis.- Dyslipidemias.- Endocrine Heart Diseases.- Antiplatelet Agents, Anticoagulants, Factor XA Inhibitors, Thrombin Inhibitors.- Cardiac Drugs During Pregnancy and Lactation.- Effects of Drug Interactions.- Hallmark Clinical Trials.- Management of Cardiomyopathies.- Newer Agents.